Study wrapper · #261
Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH.
Editor's note
This is a small physiology study - five pregnant women given sermorelin just before elective caesarean section, compared with five given saline - designed to probe how growth-hormone secretion is regulated in the mother and fetus at term. It is not an efficacy or safety study of sermorelin as an intervention, and the peptide here is a research probe of a normal biological question. The researchers report that sermorelin produced only a small, non-significant rise in maternal pituitary growth hormone (P = 0.08), did not change placental growth hormone, and was undetectable in cord blood despite being measurable in the mother's blood. The interpretation - that pituitary growth-hormone output is suppressed in late pregnancy, and that the peptide does not cross the placenta - is plausible but rests on a very small sample with no formal statistical significance for the key finding. For readers, this study speaks to reproductive physiology, not to sermorelin's proposed adult uses, and carries essentially no bearing on those.
Plain-language abstract
This small study looked at how growth hormone is controlled in pregnant women and their unborn babies near the end of pregnancy. Five women about to have a planned caesarean section received an injection of sermorelin (a peptide that normally prompts the pituitary gland to release growth hormone), and five received a saltwater placebo. Researchers then measured growth-hormone levels in the mothers and in the babies' umbilical-cord blood at birth, on average about 20 minutes after the injection. Sermorelin caused only a small rise in the mothers' own growth hormone, which was not statistically significant, and did not change the level of the placenta's separate form of growth hormone. Importantly, sermorelin could be measured in the mothers' blood but was undetectable in the babies' cord blood. The authors concluded that a mother's pituitary growth-hormone output appears turned down late in pregnancy, that sermorelin does not affect placental growth hormone, and that the baby's own growth-hormone production seems independent of the mother's - likely because the peptide does not cross the placenta. This was a physiology study in a very small group, not a test of sermorelin as a treatment.